Target intelligence / Profile preview

Necator americanus Glutathione-S-Transferase-1 (Na-GST-1) (Na-GST-1)

Target
Na-GST-1
Molecular classification
Enzyme, Glutathione S-transferase family
01

Overview

Necator americanus Glutathione-S-Transferase-1 (Na-GST-1) is a 24 kDa enzyme expressed by the human hookworm, a major cause of iron-deficiency anemia in tropical regions (Zhan et al., 2005, J Biol Chem). The enzyme is localized to the parasite's alimentary canal and plays a vital role in detoxifying host-derived heme, which is released during the digestion of blood (Asojo et al., 2007, J Mol Biol). By binding and sequestering these toxic heme molecules, Na-GST-1 prevents oxidative damage to the worm's internal tissues. Because this detoxification process is essential for the parasite's survival and fecundity, Na-GST-1 has been prioritized as a leading recombinant vaccine candidate (Bethony et al., 2011, Vaccine). Clinical development focuses on inducing host antibodies that neutralize the enzyme's catalytic and binding sites, effectively starving the parasite or causing lethal heme toxicity (Diemert et al., 2017, PLoS Negl Trop Dis). This target is particularly attractive because its structure is distinct from human glutathione S-transferases, minimizing the risk of autoimmune cross-reactivity.

Other names
Na-GST-1Glutathione S-transferase 1Hookworm Glutathione S-transferase
02

Mechanism of action

The vaccine induces host IgG antibodies that bind to the Na-GST-1 enzyme in the hookworm gut, inhibiting its ability to detoxify heme and leading to parasite mortality or reduced fecundity (Diemert et al., 2017, PLoS Negl Trop Dis).

03

Biological functions

DetoxificationHeme bindingAntioxidant activityXenobiotic metabolism
04

Disease associations

InfectionNecatoriasisHookworm infectionHelminthiasis
05

Safety considerations

Injection site reactions (pain, swelling, erythema)Potential for hypersensitivity in individuals with prior hookworm exposureImmunogenicity variability in different populations
06

Interacting drugs

Na-GST-1 vaccine

2 more in the full profile.

07

Biomarkers

Anti-Na-GST-1 IgG antibody titersFecal egg count (FEC) reduction

Beyond the preview

Go deeper on Necator americanus Glutathione-S-Transferase-1 (Na-GST-1) (Na-GST-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Necator americanus Glutathione-S-Transferase-1 (Na-GST-1) (Na-GST-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call